HOME >> MEDICINE >> NEWS
First head-to-head study to compare lidoderm patch and Celebrex in treating pain

up.

About Lidoderm
Lidoderm (lidocaine patch 5%) is FDA-approved for the relief of pain associated with post herpetic neuralgia (PHN). Lidoderm produces an analgesic effect by the penetration of lidocaine from the patch into the epidermal and dermal layers of the skin, without loss of sensation or numbness. The Lidoderm patch should only be applied to intact skin. The most frequently reported adverse events with the Lidoderm patch are application site reactions, including erythema, edema, discoloration, burning sensation, pruritus or abnormal sensation. These reactions are generally mild and transient, resolving spontaneously within a few minutes to hours.

The FDA-approved dosing for Lidoderm is up to three patches applied for up to 12 hours within a 24-hour period. Lidoderm has not been approved by the FDA for any indications other than for the relief of pain associated with PHN, and its safety and efficacy in other indications have not been established.

About Endo
A wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc. (Nasdaq: ENDP), Endo Pharmaceuticals is a fully integrated specialty pharmaceutical company with market leadership in pain management products. The company researches, develops, produces and markets a broad product offering of branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available online at www.endo.com.


'"/>

Contact: Fiona Buraimoh
fiona_buraimoh@nyc.cohnwolfe.com
212-798-9512
Cohn & Wolfe
31-Mar-2005


Page: 1 2 3

Related medicine news :

1. First UK cases of previously rare disease reported in gay men
2. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
3. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
4. First US kidney cancer vaccine trial underway at Columbia
5. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
6. First blood test to diagnose paralyzing, blinding disease
7. First US SARS vaccine trial opens at NIH
8. First-ever safety study of medical cannabis use in Canada launched
9. First solid evidence that the study of music promotes intellectual development
10. First medical test on CD gets good results
11. First proof that cutting Rx drugs due to cost harms health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 16, 2018 , ... ... Bethesda, MD, http://www.fdanews.com/fdainspectionssummit , The 13th Annual FDA Inspections Summit starts ... that it sometimes feels difficult to keep up. The FDA is focused on ...
(Date:10/16/2018)... Texas (PRWEB) , ... October ... ... (HCP), a Texas-based healthcare and clinical research networking-technology company founded by patient-survivors, ... improving quality and compliance in the clinical trial execution process, today announced ...
(Date:10/13/2018)... ... October 13, 2018 , ... ... Sports, Fitness & Nutrition, has announced LaRhonda Burley as its new Vice President ... chartered in 2010 to support and strengthen the mission of the President's Council ...
(Date:10/11/2018)... ... October 11, 2018 , ... Bizmatics Inc. is a ... and specialties. PrognoCIS , their Health IT Software – provides physicians with ... Houston Healthconnect (GHH), the region’s health information exchange (HIE), serves 24 counties in ...
(Date:10/6/2018)... ... October 06, 2018 , ... Jose ... in Miami. , Haute Beauty, well known for their exclusivity, and luxurious ... aesthetic surgeon and our newest addition to the Haute Living network. , ...
Breaking Medicine News(10 mins):
(Date:10/11/2018)... LIVONIA, Mich. (PRWEB) , ... ... ... leading provider of consumer communications, billing, and payments solutions, announced today that ... The combination makes RevSpring a premier healthcare provider of patient revenue cycle ...
(Date:10/11/2018)... ... , ... In the last four months it has also obtained grant of ... six more in USA, China and Japan from three other patent families covering the ... products. , The patents assigned from QinetiQ include US 7113092, titled “Ferromagnetic Object Detector” ...
(Date:10/7/2018)... , ... October 07, 2018 , ... Dr. B. Aviva ... , Dr. Preminger is an Ivy League-educated, Board Certified woman plastic surgeon specializing ... Haute Beauty Network, well known for their exclusivity, and luxurious lifestyle publication is privileged ...
Breaking Medicine Technology:
Cached News: